Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging

Science Translational Medicine

Volumn 7, Issue 271, 2015, Pages

  Harmsen, Stefan ^a   Huang, Ruimin ^a   Wall, Matthew A ^a,b   Karabeber, Hazem ^a   Samii, Jason M ^a   Spaliviero, Massimiliano ^c   White, Julie R ^a,d   Monette, Sébastien ^a,d   O'Connor, Rachael ^a   Pitter, Kenneth L ^a   Sastra, Stephen A ^e   Saborowski, Michael ^a   Holland, Eric C ^f   Singer, Samuel ^a   Olive, Kenneth P ^e   Lowe, Scott W ^a,g   Blasberg, Ronald G ^a   Kircher, Moritz F ^a,h  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Sidney Kimmel Center for Prostate and Urologic Cancers   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; SURFACE ENHANCED RESONANCE RAMAN SCATTERING NANOSTAR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER TISSUE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENCAPSULATION; GENETICALLY ENGINEERED MOUSE STRAIN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PINOCYTOSIS; PRECANCER; PROSTATE CANCER; RAMAN SPECTROMETRY; SARCOMA; SYNTHESIS; TUMOR XENOGRAFT; ANIMAL; DIAGNOSTIC IMAGING; DISEASE MODEL; FEMALE; HUMAN; NEOPLASMS; PATHOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASMS; PINOCYTOSIS; PRECANCEROUS CONDITIONS; SPECTRUM ANALYSIS, RAMAN; TISSUE DISTRIBUTION;

EID: 84921757074     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3010633     Document Type: Article

References (44)

1. M. F. Kircher, H. Hricak, S.M. Larson, Molecular imaging for personalized cancer care. Mol. Oncol. 6, 182-195 (2012).
2. M. F. Kircher, J. K. Willmann, Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263, 633-643 (2012).
3. M. F. Kircher, J. K. Willmann, Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology 264, 349-368 (2012).
4. L. V. Wang, S. Hu, Photoacoustic tomography: In vivo imaging from organelles to organs. Science 335, 1458-1462 (2012).
5. S. Gioux, H. S. Choi, J. V. Frangioni, Image-guided surgery using invisible near-infrared light: Fundamentals of clinical translation. Mol. Imaging 9, 237-255 (2010).
6. R. Weissleder, M. J. Pittet, Imaging in the era of molecular oncology. Nature 452, 580-589 (2008).
7. M. F. Kircher, A. de la Zerda, J. V. Jokerst, C. L. Zavaleta, P. J. Kempen, E. Mittra, K. Pitter, R. Huang, C. Campos, F. Habte, R. Sinclair, C. W. Brennan, I. K. Mellinghoff, E. C. Holland, S. S. Gambhir, A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat. Med. 18, 829-834 (2012).
8. C. L. Zavaleta, M. F. Kircher, S. S. Gambhir, Raman's "effect" on molecular imaging. J. Nucl. Med. 52, 1839-1844 (2011).
9. E. C. Le Ru, E. Blackie, M. Meyer, P. G. Etchegoin, Surface enhanced Raman scattering enhancement factors: A comprehensive study. J. Phys. Chem. C 111, 13794-13803 (2007).
10. S. Nie, S. R. Emory, Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 275, 1102-1106 (1997).
11. J. R. Lombardi, R. L. Birke, The theory of surface-enhanced Raman scattering. J. Chem. Phys. 136, 144704 (2012).
12. S. E. Bohndiek, A. Wagadarikar, C. L. Zavaleta, D. Van de Sompel, E. Garai, J. V. Jokerst, S. Yazdanfar, S. S. Gambhir, A small animal Raman instrument for rapid, wide-area, spectroscopic imaging. Proc. Natl. Acad. Sci. U.S.A. 110, 12408-12413 (2013).
13. J. L. Demers, S. C. Davis, B. W. Pogue, M. D. Morris, Multichannel diffuse optical Raman tomography for bone characterization in vivo: A phantom study. Biomed. Opt. Express 3, 2299-2305 (2012).
14. C. L. Zavaleta, E. Garai, J. T. Liu, S. Sensarn, M. J. Mandella, D. Van de Sompel, S. Friedland, J. Van Dam, C. H. Contag, S. S. Gambhir, A Raman-based endoscopic strategy for multiplexed molecular imaging. Proc. Natl. Acad. Sci. U.S.A. 110, E2288-E2297 (2013).
15. G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483 (2005).
16. K. Ellwood-Yen, T. G. Graeber, J. Wongvipat, M. L. Iruela-Arispe, J. Zhang, R. Matusik, G. V. Thomas, C. L. Sawyers, Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223-238 (2003).
17. M. Serrano, H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, R. A. DePinho, Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
18. C. T. Guy, R. D. Cardiff, W. J. Muller, Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961 (1992).
19. S. Singer, N. D. Socci, G. Ambrosini, E. Sambol, P. Decarolis, Y. Wu, R. O'Connor, R. Maki, A. Viale, C. Sander, G. K. Schwartz, C. R. Antonescu, Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res. 67, 6626-6636 (2007).
20. C. Commisso, S. M. Davidson, R. G. Soydaner-Azeloglu, S. J. Parker, J. J. Kamphorst, S. Hackett, E. Grabocka, M. Nofal, J. A. Drebin, C. B. Thompson, J. D. Rabinowitz, C. M. Metallo, M. G. Vander Heiden, D. Bar-Sagi, Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633-637 (2013).
21. S. Vranic, N. Boggetto, V. Contremoulins, S. Mornet, N. Reinhardt, F. Marano, A. Baeza-Squiban, S. Boland, Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part. Fibre Toxicol. 10, 2 (2013).
22. T. J. Stewart, S. I. Abrams, Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth. J. Immunol. 179, 2851-2859 (2007).
23. J. P. Morton, P. Timpson, S. A. Karim, R. A. Ridgway, D. Athineos, B. Doyle, N. B. Jamieson, K. A. Oien, A. M. Lowy, V. G. Brunton, M. C. Frame, T. R. Evans, O. J. Sansom, Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc. Natl. Acad. Sci. U.S.A. 107, 246-251 (2010).
24. P. A. Watson, K. Ellwood-Yen, J. C. King, J. Wongvipat, M. M. Lebeau, C. L. Sawyers, Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Cancer Res. 65, 11565-11571 (2005).
25. S. Falcone, E. Cocucci, P. Podini, T. Kirchhausen, E. Clementi, J. Meldolesi, Macropinocytosis: Regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 119, 4758-4769 (2006).
26. S. Gold, P. Monaghan, P. Mertens, T. Jackson, A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells. PLOS One 5, e11360 (2010).
27. L. M. Liz-Marzán, M. Giersig, P. Mulvaney, Synthesis of nanosized gold-silica core-shell particles. Langmuir 12, 4329-4335 (1996).
28. G. von Maltzahn, A. Centrone, J. H. Park, R. Ramanathan, M. J. Sailor, T. A. Hatton, S. N. Bhatia, SERS-coded gold nanorods as a multifunctional platform for densely multiplexed near-infrared imaging and photothermal heating. Adv. Mater. 21, 3175-3180 (2009).
29. H. Yuan, Y. Liu, A. M. Fales, Y. L. Li, J. Liu, T. Vo-Dinh, Quantitative surface-enhanced resonant Raman scattering multiplexing of biocompatible gold nanostars for in vitro and ex vivo detection. Anal. Chem. 85, 208-212 (2013).
30. Y. Takeuchi, N. Hanaoka, M. Hanafusa, R. Ishihara, K. Higashino, H. Iishi, N. Uedo, Autofluorescence imaging of early colorectal cancer. J. Biophotonics 4, 490-497 (2011).
31. M. Höckel, N. Dornhöfer, The hydra phenomenon of cancer: Why tumors recur locally after microscopically complete resection. Cancer Res. 65, 2997-3002 (2005).
32. N. Houssami, P. Macaskill, M. L. Marinovich, J. M. Dixon, L. Irwig, M. E. Brennan, L. J. Solin, Meta-analysis of the impact of surgical margins on local recurrence in women with earlystage invasive breast cancer treated with breast-conserving therapy. Eur. J. Cancer 46, 3219-3232 (2010).
33. S. E. Singletary, Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am. J. Surg. 184, 383-393 (2002).
34. H. Maeda, H. Nakamura, J. Fang, The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65, 71-79 (2013).
35. T. L. Andresen, Evalution of the EPR effect in dogs with spontaneous tumors and its implications on nanotherapies. Abstracts of Papers of the American Chemical Society 246, (2013).
36. A. Neesse, P. Michl, K. K. Frese, C. Feig, N. Cook, M. A. Jacobetz, M. P. Lolkema, M. Buchholz, K. P. Olive, T. M. Gress, D. A. Tuveson, Stromal biology and therapy in pancreatic cancer. Gut 60, 861-868 (2011).
37. J. Folkman, K. Watson, D. Ingber, D. Hanahan, Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61 (1989).
38. A. S. Thakor, R. Luong, R. Paulmurugan, F. I. Lin, P. Kempen, C. Zavaleta, P. Chu, T. F. Massoud, R. Sinclair, S. S. Gambhir, The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci. Transl. Med. 3, 79ra33 (2011).
39. A. S. Thakor, S. S. Gambhir, Nanooncology: The future of cancer diagnosis and therapy. CA Cancer J. Clin. 63, 395-418 (2013).
40. E. Garai, S. Sensarn, C. L. Zavaleta, D. Van de Sompel, N.O. Loewke, M. J. Mandella, S. S. Gambhir, C. H. Contag, High-sensitivity, real-time, ratiometric imaging of surface-enhanced Raman scattering nanoparticles with a clinically translatable Raman endoscope device. J. Biomed. Opt. 18, 096008 (2013).
41. N. Stone, M. Kerssens, G. R. Lloyd, K. Faulds, D. Graham, P. Matousek, Surface enhanced spatially offset Raman spectroscopic (SESORS) imaging - The next dimension. Chem. Sci. 2, 776-780 (2011).
42. R. H. Hruban, N. V. Adsay, J. Albores-Saavedra, M. R. Anver, A. V. Biankin, G. P. Boivin, E. E. Furth, T. Furukawa, A. Klein, D. S. Klimstra, G. Kloppel, G. Y. Lauwers, D. S. Longnecker, J. Luttges, A. Maitra, G. J. Offerhaus, L. Pérez-Gallego, M. Redston, D. A. Tuveson, Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations. Cancer Res. 66, 95-106 (2006).
43. A. Morozov, R. J. Downey, J. Healey, A. L. Moreira, E. Lou, A. Franceschino, Y. Dogan, R. Leung, M. Edgar, M. LaQuaglia, R. G. Maki, M. A. Moore, Benign mesenchymal stromal cells in human sarcomas. Clin. Cancer Res. 16, 5630-5640 (2010).
44. D. Hambardzumyan, N. M. Amankulor, K. Y. Helmy, O. J. Becher, E. C. Holland, Modeling adult gliomas using RCAS/t-va technology. Transl. Oncol. 2, 89-95 (2009).